Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017

Race, ethnicity, sex, and age are demographic factors that can influence drug exposure and/or response, and can consequently affect treatment outcome. We evaluated demographic subgroup enrollment patterns in new therapeutic products approved by the US Food and Drug Administration (FDA) for the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramamoorthy, Anuradha, Knepper, Todd C., Merenda, Christine, Mendoza, Martin, McLeod, Howard L., Bull, Jonca, Zhang, Lei, Pacanowski, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220929/
https://www.ncbi.nlm.nih.gov/pubmed/30218447
http://dx.doi.org/10.1002/cpt.1180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220929/
https://www.ncbi.nlm.nih.gov/pubmed/30218447
http://dx.doi.org/10.1002/cpt.1180

Ejemplares similares